Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Glabellar Lines”

81 trials

Showing 20 of 81 results

Very early researchStudy completedNCT05129319
What this trial is testing

Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 30
Post-approval studies (Phase 4)Study completedNCT00856414
What this trial is testing

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Skin Aging
Allergan 45
Testing effectiveness (Phase 2)Study completedNCT06199336
What this trial is testing

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. 190
Large-scale testing (Phase 3)Study completedNCT03216408
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Medy-Tox 504
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Looking for participantsNCT06205797
What this trial is testing

To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)

Who this might be right for
Glabellar Lines
Huons Biopharma 312
Large-scale testing (Phase 3)Study completedNCT05148000
What this trial is testing

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Who this might be right for
Glabellar Frown LinesCanthal Lines
Galderma R&D 25
Large-scale testing (Phase 3)Study completedNCT04830345
What this trial is testing

Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
EuBiologics Co.,Ltd 290
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Large-scale testing (Phase 3)Study completedNCT05321979
What this trial is testing

Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 253
Large-scale testing (Phase 3)Study completedNCT03837561
What this trial is testing

The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 136
Early research (Phase 1)Study completedNCT06212960
What this trial is testing

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 20
Large-scale testing (Phase 3)Study completedNCT04225260
What this trial is testing

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Who this might be right for
Glabellar LinesLateral Canthal Lines
Galderma R&D 902
Large-scale testing (Phase 3)Study completedNCT05380154
What this trial is testing

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 500
Very early researchUnknownNCT05083286
What this trial is testing

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Study completedNCT03014622
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Revance Therapeutics, Inc. 303
Large-scale testing (Phase 3)Study completedNCT06124794
What this trial is testing

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 155
Large-scale testing (Phase 3)Study completedNCT05059587
What this trial is testing

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 318
Large-scale testing (Phase 3)Study completedNCT05531968
What this trial is testing

Treatment of Moderate to Severe Glabellar Lines (BMI2006)

Who this might be right for
Glabellar Lines
BMI Korea 278
Large-scale testing (Phase 3)Study completedNCT01791920
What this trial is testing

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Who this might be right for
Skin Aging
Hugel 262
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation